Skip to main content
SpringerLink
Log in

Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation

  • Research Article
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Atorvastatin is a 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor used in the treatment of atherosclerosis and dyslipidemia. Studies have evaluated the utility of statins in the treatment of skin inflammation but with varied results. In the present study, we investigated the effect of atorvastatin on TNF-α release and keratinocyte proliferation in vitro and in acute and chronic 12-O-tetradecanoylphorbol-13-acetate (TPA) induced skin inflammation in vivo. Atorvastatin significantly inhibited lipopolysacharide induced TNF-α release in THP-1 cells and keratinocyte proliferation in HaCaT cells. In an acute study, topical atorvastatin showed dose dependent reduction in TPA induced skin inflammation with highest efficacy observed at 500 µg/ear dose. In chronic study, topical atorvastatin significantly reduced TPA induced ear thickness, ear weight, cutaneous cytokines, MPO activity and improved histopathological features comparable to that of dexamethasone. Atorvastatin also inhibited TPA stimulated NF-κB activation in mouse ear. In conclusion, our results suggest that atorvastatin ameliorates TPA induced skin inflammation in mice at least in part, due to inhibition of cytokine release and NF-κB activation and may be beneficial for the treatment skin inflammation like psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Adami, M., A.D.S. Prudente, D.A.G.B. Mendes, C.D.S. Horinouchi, D.A. Cabrini, and M.F. Ouki. 2012. Simvastatin ointment, a new treatment for skin inflammatory conditions. Journal of Dermatological Science 66: 127–135.

    Article  CAS  PubMed  Google Scholar 

  • Amigo, M., M. Paya, S. De Rosa, and M.C. Terencio. 2007. Antipsoriatic effects of avarol-3-thiosalicylate are mediated by inhibition of TNF-α generation and NF-kB activation in mouse skin. British Journal of Pharmacology 152: 353–365.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Banno, T., A. Gazel, and M. Blumenberg. 2005. Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes. Journal of Biological Chemistry 280: 18973–18980.

    Article  CAS  PubMed  Google Scholar 

  • Blanco-Colio, L.M., J. Tunon, J.L. Martin-Ventura, and J. Egido. 2003. Antiinflammatory and immunomodulatory effects of statins. Kidney International 63: 12–23.

    Article  CAS  PubMed  Google Scholar 

  • Boehncke, W., K. Hardt-Weinelt, H. Nilsson, M. Wolter, M. Dohlsten, F.R. Ochsendorf, R. Kufmann, and P. Antonsson. 2001. Anatagnoistic effects of the staphylococcal enterotoxin a mutant, SEA on psoriasis in SCID-hu xenogeneic transplantation model. Journal of Investigative Dermatology 116: 596–601.

    Article  CAS  PubMed  Google Scholar 

  • Bracht, L., S.M. Caparroz-Assef, T.F.S. Magon, A.M.V. Ritter, R.K.N. Cuman, and C.A. Bersani-Amado. 2011. Topical anti-inflammatory effect of hypocholesrolemic drugs. Journal of Pharmacy and Pharmacology 63: 971–975.

    Article  CAS  PubMed  Google Scholar 

  • Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology 78: 206–209.

    Article  CAS  PubMed  Google Scholar 

  • Gottlieb, A.B. 2005. Therapeutic options in the treatments of psoriasis and atopic dermatitis. Journal of the American Academy of Dermatology 53: S3–S16.

    Article  PubMed  Google Scholar 

  • Johnson-Huang, L.M., N.S. McNutt, J.G. Krueger, and M.A. Lowes. 2009. Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases. Journal of Clinical Immunology 29: 247–256.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kumar, K.G., R. Damotharan, N.M. Kulkarni, M.Y.A. Mahat, J. Gunasekaran, and M. Ashfaque. 2011. Embelin reduces cutaneous TNF-α level and ameliorate skin edema in acute and chronic model of skin inflammation in mice. European Journal of Pharmacology 662: 63–69.

    Article  Google Scholar 

  • Kundu, J.K., Y.K. Shin, and Y.J. Surh. 2006. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochemical Pharmacology 72: 1506–1515.

    Article  CAS  PubMed  Google Scholar 

  • Levy, J.H. 1996. The human inflammatory response. Journal of Cardiovascular Pharmacology 27(1): S31–S37.

    Article  CAS  PubMed  Google Scholar 

  • Li, M., X. Zhong, Z. He, M. Wen, J. Li, X. Peng, G. Liu, et al. 2012. Effect of erythromycin on cigarette-induced histone deacetylase protein expression and nuclear factor-κB activity in human macrophages in vitro. International Immunopharmacology 12(4): 643–650.

    Article  CAS  PubMed  Google Scholar 

  • Lowes, M.A., A.M. Bowcock, and J.G. Krueger. 2007. Pathogenesis and therapy of psoriasis. Nature 22: 866–873.

    Article  Google Scholar 

  • Namazi, M.R. 2004. Statins: novel additions to the dermatological arsenal? Experimental Dermatology 13: 337–339.

    Article  CAS  PubMed  Google Scholar 

  • Ortego, M., C. Bustos, M.A. Harnandez-Presa, J. Tunon, C. Diaz, G. Hernandez, et al. 1999. Atorvastatin reduces NF-kB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147: 253–261.

    Article  CAS  PubMed  Google Scholar 

  • Quivy, V., and C. Van Lint. 2004. Regulation at multiple levels of NF- kappa B-mediated transactivation by protein acetylation. Biochemical Pharmacology 68: 1221–1229.

    Article  CAS  PubMed  Google Scholar 

  • Stanley, P.L., S. Steiner, M. Havens, and K.M. Tramposch. 1991. Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacology 4: 262–271.

    Article  CAS  PubMed  Google Scholar 

  • Wei, W., S. Lin, Y. Chen, C. Wen, C. Huang, A. Palanisamy, et al. 2011. Topical application of marine briarane-type diterpenes effectively inhibits 12-O-tetradecanoylphorbol-13-acetate- induced inflammation and dermatitis in murine skin. Journal of Biomedical Science 18: 94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yang, S.S., R. Li, X. Qu, W. Fang, and Z. Quan. 2012. Atorvastatin decreases toll-like receptor 4 expression and downstream signaling in human monocyte leukemia cells. Cellular Immunology 279: 96–102.

    Article  CAS  PubMed  Google Scholar 

  • Youssef, S., O. Stuve, J.C. Patarroyo, P.J. Ruiz, J.L. Radosevich, E.M. Hur, et al. 2002. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420: 78–84.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology, Drug Discovery Research, Orchid Chemicals and Pharmaceuticals Ltd., Old Mahabalipuram Road, Shozhanganallur, Chennai, 600119, India

    Nagaraj M. Kulkarni, Milind M. Muley, Mallikarjun S. Jaji, G. Vijaykanth, J. Raghul, Neetin Kumar D. Reddy, Santosh L. Vishwakarma, Navin B. Rajesh, Jeyamurugan Mookkan & Shridhar Narayanan

  2. Centre for Nanotechnology and Advanced Biomaterials (CeNTAB), School of Chemical and Biotechnology, SASTRA University, Thanjavur, 613401, India

    Nagaraj M. Kulkarni, Uma Maheswari Krishnan & Shridhar Narayanan

  3. Infection iScience, AstraZeneca India Pvt. Ltd., Off Bellary Road, Hebbal, Bangalore, 560024, India

    Shridhar Narayanan

Authors
  1. Nagaraj M. Kulkarni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Milind M. Muley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mallikarjun S. Jaji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Vijaykanth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Raghul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Neetin Kumar D. Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Santosh L. Vishwakarma
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Navin B. Rajesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jeyamurugan Mookkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Uma Maheswari Krishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shridhar Narayanan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shridhar Narayanan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kulkarni, N.M., Muley, M.M., Jaji, M.S. et al. Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation. Arch. Pharm. Res. 38, 1238–1247 (2015). https://doi.org/10.1007/s12272-014-0496-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-014-0496-0

Keywords

Search

Navigation